Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sajida Ibrahim

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Molecules (Basel, Switzerland)|February 10, 2021
New Quinoxaline Derivatives as Dual Pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological EvaluationBruno Oyallon, Marie Brachet-Botineau, Cédric Logé, et al.
American Journal of Respiratory Cell and Molecular Biology|November 8, 2024
Enhanced Gαq Signaling in <i>TSC2</i>-Deficient Cells Is Required for Their Neoplastic BehaviorAurélie Tréfier, Nihad Tousson-Abouelazm, Lama Yamani, et al.
Cellular and Molecular Life Sciences : CMLS|May 8, 2022
Curcumin and NCLX inhibitors share anti-tumoral mechanisms in microsatellite-instability-driven colorectal cancerMaxime Guéguinou, Sajida Ibrahim, Jérôme Bourgeais, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Molecules (Basel, Switzerland)|February 10, 2021
New Quinoxaline Derivatives as Dual Pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological EvaluationBruno Oyallon, Marie Brachet-Botineau, Cédric Logé, et al.
American Journal of Respiratory Cell and Molecular Biology|November 8, 2024
Enhanced Gαq Signaling in <i>TSC2</i>-Deficient Cells Is Required for Their Neoplastic BehaviorAurélie Tréfier, Nihad Tousson-Abouelazm, Lama Yamani, et al.
Cellular and Molecular Life Sciences : CMLS|May 8, 2022
Curcumin and NCLX inhibitors share anti-tumoral mechanisms in microsatellite-instability-driven colorectal cancerMaxime Guéguinou, Sajida Ibrahim, Jérôme Bourgeais, et al.
Pageof 2